Iraq
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Iraq (IQ)
2000 | 449.9 thousand |
2011 | 1.1 million |
2024 | 2.7 million |
2050 | 5.9 million |
Iraq is one of the 21 countries and territories in the IDF Middle-East and North Africa Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2006.
- Iraq Ministry of Health. Iraq Family Health Survey 2006/7
- WHO STEPS 2015
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 449.9 | 1,089.0 | 2,669.4 | 5,881.4 |
Age-standardised prevalence of diabetes, % | - | 9.1 | 13.4 | 14.9 |
Proportion of people with undiagnosed diabetes, % | - | - | 47.1 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 1,256.0 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 2,042.0 | 4,182.6 |
Age-standardised prevalence of IFG, % | - | - | 9.2 | 9.8 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 945.4 | 1,765.9 | 3,699.1 |
Age-standardised prevalence of IGT, % | - | 7.5 | 8.6 | 9.1 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 13,085.0 | 14,683.1 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 11.7 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 2,078.0 | 3,888.1 |
Total diabetes-related health expenditure, ID million | - | - | 6,214.1 | 11,627.4 |
Diabetes-related health expenditure per person, USD | - | 182.0 | 778.4 | 661.1 |
Diabetes-related health expenditure per person, ID | - | - | 2,327.9 | 1,977.0 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 65,550.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 25,393.6 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 10,945.0 | 15,068.7 | 24,364.8 | 46,091.2 |
Population of children and adolescents (0-19 y) | - | - | 21,622,351.5 | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 449.9 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 10,945.0 |
Population of children and adolescents (0-19 y) | - |